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Pericardial Flap Interposition for the Definitive Management of 
Recurrent Tracheoesophageal Fistula 
By Michael J. Wheatley and Arnold G. Coran 
Ann Arbor, Michigan 
0 From 1974 to 1988, six children with fistula recurrence 
following primary tracheoesophageal fistula (TEF) repair 
have been managed at our hospital. Reclosure of the fistula 
with pleural flap interposition was used as the initial correc- 
tive procedure in five patients, with an 80% incidence of 
second TEF recurrences. Due to these discouraging results, 
we have abandoned this technique and instead favor fistula 
reclosure with interposition of a pedicle of vascularized 
pericardium between the esophageal and tracheal suture 
lines. The pericardial pedicle is easy to mobilize, effectively 
isolates the tracheal and esophageal suture lines, and elimi- 
nates the often difficult task of finding sufficient pleural 
tissue for fistula interposition in small infants. Furthermore, 
the vascularized pedicle serves as a template for the in- 
growth of neomucosa from the existing esophageal mucosa 
should an anastomotic leak occur. Since adopting this ap- 
proach, we have used this technique on four children, three 
of whom had second recurrences after pleural interposition, 
and have had no evidence of recurrent fistula formation at 
follow-up ranging from 2 to 6 years. With at least a 20% 
incidence of second recurrences reported following conven- 
tional management with fistula closure and pleural interposi- 
tion, we believe use of a pericardial flap in the management 
of the recurrent TEF is the most appropriate surgical proce- 
dure. 
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P ERHAF’S the most vexing problem following primary repair of tracheoesophageal fistula 
(TEF) and esophageal atresia (EA) is recurrence of 
the TEF. Once thought to be a rare complication, 
TEF recurrence has a reported incidence between 
5% and 11%.le3 While the diagnosis of a recurrent 
fistula can be elusive, the surgical management is 
even more problematic with second recurrences not 
at all uncommon following fistula reclosure and 
pleural interposition. In 1986, we reported on the use 
of a pericardial hap to manage a child with a 
recurrent TEF.4 Over the past 3 years, this procedure 
has been used on four patients, three of whom had 
second recurrences after conventional surgical clo- 
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sure of their recurrent fistula. It has proven to be an 
invaluable technique for managing this difficult com- 
plication. 
MATERIALS AND METHODS 
From January 1974 to December 1988,80 neonates with EA or 
EA and TEF presented to the Mott Children’s Hospital, and 67 
were successfully managed with division of the TEF and a 
one-layer 5-O silk end-to-end esophagoesophagostomy as a single 
or staged procedure. All repairs were done through a right 
retropleural thoracotomy. Placement of a Stamm feeding gastros- 
tomy was performed in 59 of the 67 children either prior to or at the 
time of EA repair. During this interval, six patients developed a 
recurrent TEF. One child was asymptomatic and his fistula was 
noted on a routine postoperative barium study 1 week following the 
primary repair. The remaining five all had severe respiratory 
problems that mandated search for a recurrence. Diagnosis was 
made endoscopically in one child and with barium tube esophago- 
grams in the remainder. Five of the six developed the recurrence 
within 3 months of their initial TEF repair and the sixth presented 
23 months following her initial surgery with a respiratory arrest. 
RESULTS 
As the initial corrective procedure, five of the 
patients underwent reclosure of the fistula with inter- 
position of a piece of pleural tissue to separate the 
esophageal and tracheal closures. Only one of these 
five children did well following surgery. This child had 
a pinpoint fistula that did not recur after the reclo- 
sure. The other four developed a second recurrence 
of their TEF, all within 5 months following initial 
reclosure (Fig 1). One of the four patients with a 
second recurrence died shortly after diagnosis from 
complications related to her multiple medical prob- 
lems as well as to the TEF. The second recurrence in 
the remaining three children was managed with 
reexploration through a right transpleural thoracot- 
omy, division of the TEF and mobilization of a 
vascularized pericardial flap with interposition be- 
tween the esophageal and tracheal suture lines as 
described subsequently. All three have done well with 
no clinical or radiographic evidence of a recurrent 
fistula at follow-up ranging from 2 to 6 years (Fig 2). 
Based on our poor results with pleural interposition 
between the esophageal and tracheal suture lines, the 
sixth patient, the most recent infant with a first 
recurrence, was managed with fistula redivision and 
pericardial flap interposition as his initial corrective 
procedure and is doing well without any respiratory 
symptoms 2 years following this operation. 
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Fig 1. Barium esophrgogram showing e second recurrence follow- 
ing fistula reclosure and pleural interposition for a TEF recurrence. 
Operative Technique 
Following diagnosis of a recurrent TEF, a nasojeju- 
nal tube is passed and the child is maintained on 
enteral nutrition for a period of 4 to 6 weeks both to 
improve nutritional status and to allow resolution of 
the inflammatory reaction in the area of the recurrent 
fistula. Following adequate weight gain, the patient is 
returned to the operating room and, if possible, the 
TEF is bronchoscopically visualized and stented with 
a no. 2 Fogarty catheter to aid in intraoperative 
Fig 2. Barium esophagogram in the same patient 2 years following 
fistula reclosure with interposition of a pericardial flap showing no 
recurrence of the ffstula. 
localization (Fig 3). A right posterolateral transpleu- 
ral thoracotomy is performed and the proximal and 
distal esophagus isolated. With the aid of the stent, 
the fistula is resected leaving a cuff of esophageal 
tissue on the membranous trachea for closure (Fig 4). 
Both the esophagus and trachea are closed with 
single-layer of interrupted 5-O cardiovascular silk 
stitches. Following closure of the fistula, the right 
phrenic nerve is mobilized off the pericardium from 
the midpoint of the superior vena cava (SVC) to a 
level just below the inferior margin of the right 
atrium. Transverse incisions are then made in the 
pericardium 1 cm above and below the mobilized 
margins of the phrenic nerve and carried anteriorly 
across the right atrium. The transverse incisions are 
then joined by a vertical incision, creating a vascular- 
ized pedicle of pericardium with its base attached to 
the SVC and the right atrium (Fig 5). The pedicle of 
pericardium is then brought under the right phrenic 
nerve and interposed between the tracheal and esoph- 
ageal suture lines and secured in place with inter- 
rupted 4-O silk sutures (Fig 6). The pericardial defect 
overlying the right atrium is closed loosely with 
interrupted 4-O silk sutures and a chest tube is placed 
in the right pleural space. The chest is then closed in 
layers. A routine barium esophagogram is obtained 
on the 7th postoperative day. 
DISCUSSION 
TEF recurrence following primary EA and TEF 
repair in infancy is not a rare complication, with an 
incidence of 9% in our series of 67 patients. Documen- 
tation of a recurrence can be challenging, and, 
although barium esophagogram and endoscopy were 
diagnostic in our group, these studies are not particu- 
larly sensitive and can be misleading in failing to 
identify a tracheoesophageal communication.J This 
diagnosis must be considered and reconsidered in the 
evaluation of any postoperative EA child with persis- 
Fig 3. Preoperative identification of the fistule bronchoscopically 
allows placement of a Fogarty catheter through the fistula to act as a 
stent to aid in operative identification of the fistula. 
Fig 4. With the aid of the Fogarty stent, the fistula is isolated and 
surrounded with an O-silk tie. 
tent respiratory symptoms because not all postopera- 
tive pulmonary problems in this setting are due to 
gastroesophageal reflux or aspiration.5 A variety of 
radiologic techniques have been described to assist in 
diagnosing the recurrent TEF, including tine barium 
swallow, right lateral decubitus esophagograms, and 
prone esophagrams. 6t7 Like others, we have found the 
tube esophagogram, in which barium is injected 
under some pressure into a nasogastric tube as the 
tube is slowly pulled from the stomach to the esopha- 
gus, to be an essential part of the examination for a 
recurrent fistula.3 Repeated barium studies should be 
performed as long as recurrent TEF is suspected and 
until the diagnosis is made. This is particularly true in 
children with persistent or recurrent pulmonary symp- 
toms following closure of a recurrent TEF as second 
recurrences can occur. In our series, pulmonary 
symptoms resolved in all patients following definitive 
repair, suggesting that persistent symptoms indicate 
an ongoing anatomic abnormality and are not simply 
the inevitable pulmonary sequela of this disorder. 
Because the etiology of TEF recurrence is not well 
understood, prevention is a difficult task. Although 
the end-to-side technique appears to lead to a higher 
incidence of recurrent fistulization,8,9 the current 
series as well as others in which the end-to-end 
technique was primarily or exclusively used have a 
relatively constant recurrence rate near 10%.1-3.8JoJ1 
Fig 5. A vascularized pedicle of pericardium with its base attached 
to the SVC and right atrium is created. 
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Fig 6. Pericardial pedicle is brought under the phrenic nerve then 
interposed between the tracheal and esophageal suture lines, where 
it is sewn in place. 
Anastomotic tension during the primary repair and 
postoperative anastomotic leakage are thought to 
predispose to fistula formation3 although only 50% 
of the patients with recurrences had anastomotic 
leakage and only one anastomosis was performed 
under tension. In our experience, careful fistula 
closure with suturing of the membranous trachea and 
use of pleural or intercostal muscle pedicle grafts 
have done little to impact on the incidence of recur- 
rence. 
Once diagnosed, surgical closure of a recurrent 
fistula is mandatory as spontaneous closure is a very 
rare occurrence,2t3J1J2 and delays in surgical closure 
place the child at risk for ongoing respiratory prob- 
lems. As initially suggested by Haight,13 a 4- to 6-week 
waiting period prior to repair is beneficial because 
early operative correction may be technically difficult 
due to the marked inflammatory response often 
initially found in the area of the fistula. Nasojejunal 
tube feeding facilitates this temporizing approach 
and allows the maintenance of adequate nutrition 
without esophageal bypass and gastrostomy place- 
ment. 
The surgical management of this complication has 
evolved over the past 7 years. Our first five patients 
initially underwent division and reclosure of the 
fistula with interposition of a pleural flap. One child 
with a pinpoint fistula did well with this approach, but 
the remaining four developed a second recurrence. 
Our experience is paralleled by Ein et al, who noted a 
22% incidence of second recurrences following pleu- 
ral flap interposition. 3 One child with a second 
recurrence died prior to corrective surgery but the 
remaining three and one additional child with a 
primary recurrence have all done well following 
takedown of their recurrent fistula and interposition 
of a vascularized pericardial flap. Postoperative recov- 
ery was unremarkable in each instance, and, at 
follow-up ranging from 2 to 6 years, no recurrent 
fistulas have occurred. 
We consider pericardial flap interposition with 
fistula division to be the procedure of choice for 
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recurrent TEF. The vascularized pedicle of pericar- dence of an initial fistula recurrence is nearly lo%, 
dium effectively isolates the tracheal and esophageal the routine use of a pericardial interposition flap 
suture lines and eliminates the often difficult task of during primary EA repair is not unreasonable. How- 
finding sufficient pleural tissue for fistula interposi- ever, with at least a 20% incidence of second recur- 
tion in small infants. Furthermore, the vascularized rences reported following conventional management 
pedicle serves as a template for the ingrowth of with fistula closure and pleural interposition, we 
neomucosa from the existing esophageal mucosa believe use of a pericardial flap in the management of 
should an anastomotic leak occur.i4 Since the inci- the recurrent TEF is appropriate. 
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Discussion 
Howard Filston (Knoxville, TN): Dr Coran and his 
associates have correctly, I believe, pointed out the 
10% recurrence rate after TEF repair, which has 
been a rather universal experience. However, the 
high incidence of second recurrences is somewhat 
startling. They have offered a nice technique for 
solving the problem of finding something to interpose 
between the ligated ends of the TEF. 
I would question whether their high rate of second 
recurrence is due to missing the fistula at operation 
for the first recurrence. They mention in the manu- 
script trying to stent the fistula preoperatively through 
the bronchoscope at the second recurrence. Did they 
stent the original recurrence for definitive identifica- 
tion of the fistula at that operation? 
I find it very difficult to be certain that I have found 
these often tiny recurrent fistulas, and sometimes 
they are not where you expect them to be. Without 
such a catheter spanning the fistula, I find it very 
difficult to be certain that I have really found it and 
divided it. 
Even identifying and confirming the presence of 
the recurrent fistula by bronchoscopy can be very 
difficult, let alone successfully passing a catheter 
through it. A technique of directly probing and 
cannulating recurrent fistulas during a pullout esoph- 
agography was developed by Dr Donald Kirks when 
he was at Duke. He used catheters made especially 
for the purpose of cannulating these fistulas. 
I would ask three questions. How often did you 
cannulate the fistula at the first recurrence, and how 
often at the second recurrence? 
You advise 4 to 6 weeks of nasojejunal feedings 
between discovery of the recurrence and operation. 
Do you keep the patients hospitalized the whole 
time? If so, this may not be truly cost-effective. 
Finally, why don’t you fold the flap all the way 
underneath the trachea? It looks to me from the 
drawing as though it only partially separates the 
trachea from the esophagus, and I couldn’t really tell 
how it fits between the two closed fistula sites. 
I like the pericardial flap idea, but would recom- 
mend that it is well worth the effort to have the re- 
current fistula cannulated at the time of reoperation. 
Jerrold Becker (New York, NY): In 1982, Dr Ein 
presented the experience at Toronto with recurrent 
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TEF, and in discussing that paper I mentioned that I 
felt that a recurrent TEF is a preventable disease. 
If one ligates and divides the azygous vein laterally, 
and then at the end of the anastomosis interposes it 
by covering the tracheal closure with it and just 
suturing the vein to the endothoracic fascia, you can 
prevent recurrent TEF. 
Arnold G. Corun (response): First of all, Howard, 
we always stent them when possible. On the first 
go-around, about 90% of them were stented. On the 
second go-around, it was more difficult because of the 
circuitous nature of the fistula, and we couldn’t stent 
them all. We were only stenting about 50% of the 
cases. 
As far as the question of hospitalization is con- 
cerned, the last one of these was done 5 years ago, 
and at that time we weren’t able to have the kind of 
home nutritional support that we carry out today. I 
think today, if we had a child on nasojejunal feeding, 
we would send the child home and have them 
managed by a visiting nurse. 
As far as the diagram on coverage is concerned, the 
pericardial flap comes down, and it’s hard to show in 
the diagram, but it goes inside that groove between 
the trachea and the esophagus. It’s sitting way around 
the corner. It doesn’t look like that as well in the 
diagram, but it’s brought all the way inside there to 
cover it. 
